These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


120 related items for PubMed ID: 8863331

  • 21. Elimination of iomeprol in patients undergoing continuous ambulatory peritoneal dialysis.
    Iwamoto M, Hiroshige K, Suda T, Ohta T, Ohtani A, Nakashima Y.
    Perit Dial Int; 1999; 19(4):380-5. PubMed ID: 10507822
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Initial treatment of peritoneal dialysis peritonitis without vancomycin with a once-daily cefazolin-based regimen.
    Goldberg L, Clemenger M, Azadian B, Brown EA.
    Am J Kidney Dis; 2001 Jan; 37(1):49-55. PubMed ID: 11136167
    [Abstract] [Full Text] [Related]

  • 25. Azithromycin: an assessment of its pharmacokinetics and therapeutic potential in CAPD.
    Kent JR, Almond MK, Dhillon S.
    Perit Dial Int; 2001 Jan; 21(4):372-7. PubMed ID: 11587400
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pharmacokinetics of clindamycin in the plasma and dialysate after intraperitoneal administration of clindamycin phosphoester to patients on continuous ambulatory peritoneal dialysis: an open-label, prospective, single-dose, two-institution study.
    Chang MJ, Namgung H, Choi HD, Song YR, Kim SG, Oh JM, Shin WG.
    Basic Clin Pharmacol Toxicol; 2012 Jun; 110(6):504-9. PubMed ID: 22151828
    [Abstract] [Full Text] [Related]

  • 28. Single-dose pharmacokinetics of intraperitoneal ofloxacin in patients on continuous ambulatory peritoneal dialysis.
    Cheng IK, Chau PY, Kumana CR, Chan CY, Kou M, Siu LK.
    Perit Dial Int; 1993 Jun; 13 Suppl 2():S383-5. PubMed ID: 8399617
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysis.
    Neal D, Bailie GR.
    Clin Pharmacokinet; 1990 Jun; 18(6):485-90. PubMed ID: 2354591
    [Abstract] [Full Text] [Related]

  • 32. Pharmacokinetics of aztreonam administered i.p. in continuous ambulatory peritoneal dialysis (CAPD) patients.
    Nikolaidis P, Dombros N, Alexiou P, Balaskas E, Tourkantonis A.
    Perit Dial Int; 1989 Jun; 9(1):57-9. PubMed ID: 2488183
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pharmacokinetics of 300 mg/d Intraperitoneal Daptomycin: New Insight from the DaptoDP Study.
    Saint Paul LP, Ficheux M, Debruyne D, Loilier M, Bouvier N, Morello R, Verdon R, Le Blanc E, Cattoir V, Lobbedez T.
    Perit Dial Int; 2018 Jun; 38(6):463-466. PubMed ID: 30413641
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A comparison between intraperitoneal ciprofloxacin and intraperitoneal vancomycin and gentamicin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD).
    Friedland JS, Iveson TJ, Fraise AP, Winearls CG, Selkon JB, Oliver DO.
    J Antimicrob Chemother; 1990 Dec; 26 Suppl F():77-81. PubMed ID: 2292548
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.